Talis Biomedical Corporation (TLIS)
Largest Insider Buys in Sector
TLIS Stock Price History Chart
TLIS Stock Performance
About Talis Biomedical Corporation
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory …
Insider Activity of Talis Biomedical Corporation
Over the last 12 months, insiders at Talis Biomedical Corporation have bought $103,019 and sold $0 worth of Talis Biomedical Corporation stock.
On average, over the past 5 years, insiders at Talis Biomedical Corporation have bought $53.37M and sold $210,665 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Leonard Braden Michael (10 percent owner) — $824,150.
The last purchase of 25,000 shares for transaction amount of $37,100 was made by Leonard Braden Michael (10 percent owner) on 2024‑09‑06.
List of Insider Buy and Sell Transactions, Talis Biomedical Corporation
| 2024-09-06 | 10 percent owner | 25,000 0.3968% | $1.48 | $37,100 | +12.90% | |||
| 2024-09-05 | 10 percent owner | 5,100 0.0764% | $1.40 | $7,140 | +19.86% | |||
| 2024-09-03 | 10 percent owner | 500 0.0251% | $4.00 | $2,000 | -53.21% | |||
| 2024-08-30 | 10 percent owner | 151 0.008% | $4.25 | $642 | -60.05% | |||
| 2024-08-28 | 10 percent owner | 1,215 0.0645% | $3.96 | $4,815 | -57.32% | |||
| 2024-08-26 | 10 percent owner | 13,167 0.6969% | $3.90 | $51,322 | -56.68% | |||
| 2021-11-18 | 50,000 0.2117% | $4.37 | $218,250 | -77.36% | ||||
| 2021-08-13 | Sale | 27,502 0.1055% | $7.66 | $210,665 | -71.83% | |||
| 2021-05-17 | director | 11,000 0.0426% | $10.11 | $111,210 | -51.03% | |||
| 2021-05-14 | director | 9,000 0.0354% | $10.16 | $91,440 | -47.52% | |||
| 2021-02-17 | 6.25M 31.505% | $16.00 | $100M | -65.14% | ||||
| 2021-02-17 | director | 312,500 1.5752% | $16.00 | $5M | -65.14% | |||
| 2021-02-17 | director | 5,300 0.0267% | $16.00 | $84,800 | -65.14% | |||
| 2021-02-17 | director | 62,500 0.315% | $16.00 | $1M | -65.14% | |||
| 2021-02-17 | Sr. Vice President, Operations | 4,000 0.0202% | $16.00 | $64,000 | -65.14% | |||
| 2021-02-17 | Chief of Staff, Sr. VP, Legal | 2,000 0.0101% | $16.00 | $32,000 | -65.14% | |||
| 2021-02-17 | Chief Financial Officer | 1,700 0.0086% | $16.00 | $27,200 | -65.14% | |||
| 2021-02-17 | Sr. Vice President, R&D | 1,000 0.005% | $16.00 | $16,000 | -65.14% |
Insider Historical Profitability
| Leonard Braden Michael | 10 percent owner | 248702 13.6438% | $1.72 | 6 | 0 | |
| BAKER BROS. ADVISORS LP | 7053176 386.9377% | $1.72 | 2 | 0 | <0.0001% | |
| Popovits Kimberly J | director | 215090 11.7999% | $1.72 | 1 | 0 | <0.0001% |
| Posard Matthew L. | director | 62500 3.4288% | $1.72 | 1 | 0 | <0.0001% |
| Ramakrishnan Ramesh | 38619 2.1186% | $1.72 | 1 | 1 | <0.0001% |
Institutional Investor Ownership
| Baker Bros Advisors LP | $4.45M | 27.9 | 508,323 | 0% | +$0 | 0.03 | |
| Bml Capital Management Llc | $374,001.00 | 2.35 | 42,743 | 0% | +$0 | 0.29 | |
| The Vanguard Group | $271,364.00 | 1.7 | 31,013 | 0% | +$0 | <0.0001 | |
| Susquehanna International Group | $152,521.00 | 0.96 | 17,431 | +11.95% | +$16,274.97 | <0.0001 | |
| Prelude Capital | $130,620.00 | 0.82 | 14,928 | 0% | +$0 | 0.01 |